TLDR Over 21,000 Bitcoin options contracts valued at approximately $1.85 billion are expiring today. Around 130,000 Ethereum options contracts worth about $396 TLDR Over 21,000 Bitcoin options contracts valued at approximately $1.85 billion are expiring today. Around 130,000 Ethereum options contracts worth about $396

$2.2B in Crypto Options Expire Today as Markets Show Low Volatility

TLDR

  • Over 21,000 Bitcoin options contracts valued at approximately $1.85 billion are expiring today.
  • Around 130,000 Ethereum options contracts worth about $396 million are also set to expire today.
  • The Bitcoin options have a put-to-call ratio of 0.48, showing more long positions than short ones.
  • Ethereum options carry a put-to-call ratio of 0.6,2 reflecting a more balanced market sentiment.
  • The max pain price for Bitcoin options is near $88,00,0 which is close to the current spot price.

Crypto markets face a fresh expiry event today as over 21,000 Bitcoin and 130,000 Ethereum options contracts reach maturity, combining for a notional value of around $2.2 billion, with traders watching price levels and strike concentrations closely, while liquidity stays thin following the New Year holiday.

Bitcoin Options Expiry

A total of 21,000 Bitcoin options contracts, valued near $1.85 billion, will expire today on multiple derivatives platforms. Market activity has slowed due to the holiday period, with low volume and minimal volatility across major spot markets. As a result, this expiry event is much smaller than usual.

The put/call ratio for Bitcoin options stands at 0.48, reflecting more calls than puts in circulation this week. According to Coinglass, the max pain price is around $88,000, close to Bitcoin’s recent trading levels. This indicates that many of these contracts are likely to expire in the money.

Open interest remains concentrated at the $100,000 strike level, where $1.3 billion is currently positioned on Deribit. Bearish positions also show strength, with about $1.1 billion in open interest between the $75,000 and $80,000 strikes. These levels are critical as they represent areas of growing market pressure.

Total open interest across all exchanges for BTC options has dropped to $28 billion after last week’s major expiry. Trading volumes have stayed low during the holiday week, and sentiment is still weak across the market. Greeks Live stated this week,

Despite the slow market, Bitcoin has posted a 1.3% gain over the last 24 hours, touching nearly $89,000. However, this price range continues to act as resistance, limiting upward movement for now. Trading in Asian hours sparked this modest rally early Friday.

Ethereum Options Expiry

Roughly 130,000 Ethereum options contracts expire today, with a combined value estimated at $396 million. These contracts carry a put/call ratio of 0.62, suggesting a more balanced positioning between long and short holders. The max pain price is around $2,950, as per current data.

Total Ethereum options open interest has declined to $6.7 billion, down from levels seen in August last year. Expiring contracts may trigger some volatility, but subdued trading conditions could limit reaction. The expiry arrives without major shifts in the broader market structure.

Ethereum regained the $3,000 level early Friday, following a 1.7% price increase. This move occurred during Asian trading, where most altcoins showed slight upward momentum. Gains extended to Dogecoin, Cardano, Chainlink, and Avalanche.

Crypto analyst ‘Credibull Crypto’ noted,

Support at $74,000 remains intact, and some analysts believe a bottom may be forming around current ranges. Another analyst, ‘Daan Crypto Trades’, highlighted the new monthly candle, warning of potential early-week fakeouts.

Both Bitcoin and Ethereum prices remain near expiry max pain zones, keeping many contracts in play. The lower volume may limit large swings, but price reactions could still emerge if resistance levels break. For now, crypto markets begin the year cautiously, with attention fixed on today’s expiry numbers.

The post $2.2B in Crypto Options Expire Today as Markets Show Low Volatility appeared first on CoinCentral.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23